The role of molecular imaging in the development of dendritic cell-based cancer vaccines

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 32, Issue 7, 2005, Pages 725-730

  Lucignani, Giovanni ^a,b   Rescigno, Maria ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; DENDRITIC CELL VACCINE; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; INDIUM 111; TECHNETIUM 99M; TUMOR ANTIGEN;

ANTIGEN PRESENTATION; CANCER IMMUNOLOGY; CANCER IMMUNOTHERAPY; CELL ACTIVATION; CLINICAL TRIAL; DRUG RESEARCH; EDITORIAL; HUMAN; IMMUNOGENICITY; MOLECULAR IMAGING; VACCINATION;

ANTIGENS, NEOPLASM; CANCER VACCINES; CELL MEMBRANE; DENDRITIC CELLS; HUMANS; IMMUNOTHERAPY; MODELS, BIOLOGICAL; NEOPLASMS;

EID: 23744450435     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-005-1858-0     Document Type: Editorial

References (30)

1. Quillien V, Moisan A, Carsin A, Lesimple T, Lefeuvre C, Adamski C, et al. Biodistribution of radiolabelled human dendritic cells injected by various routes. Eur J Nucl Med Mol Imaging (in press). DOI 10.1007/s00259-005-1825-9
2. Delves PJ, Roitt IM. The immune system. First of two parts. N Engl J Med 2000;343:37-49
3. Delves PJ, Roitt IM. The immune system. Second of two parts. N Engl J Med 2000;343:108-17
4. Armstrong AC, Hawkins RE. Vaccines in oncology: background and clinical potential. Br J Radiol 2001;74:991-1002
5. Slingluff CL Jr, Speiser DE. Progress and controversies in developing cancer vaccines. J Transl Med 2005;3:18
6. Baar J. Clinical applications of dendritic cell cancer vaccines. Oncologist 1999;4:140-4
7. Levene AP, Singh G, Palmieri C. Therapeutic monoclonal antibodies in oncology. J R Soc Med 2005;98:146-52
8. Yee C. Adoptive T cell therapy: addressing challenges in cancer immunotherapy. J Transl Med 2005;3:17
9. Banchereau J, Palucka AK. Dendritic cells as therapeutic vaccines against cancer. Nat Rev Immunol 2005;5:296-306
10. Costello RT, Fauriat C, Rey J, Gastaut JA, Olive D. Immunobiology of haematological malignant disorders: the basis for novel immunotherapy protocols. Lancet Oncol 2004;5:47-55
11. Zippelius A, Batard P, Rubio-Godoy V, Bioley G, Lienard D, Lejeune F, et al. Effector function of human tumor-specific CD8 T cells in melanoma lesions: a state of local functional tolerance. Cancer Res 2004;64:2865-73
12. Rescigno M, Granucci F, Ricciardi-Castagnoli P. Dendritic cells at the end of the millennium. Immunol Cell Biol 1999;77:404-10
13. Vieweg J, Jackson A. Modulation of antitumor responses by dendritic cells. Springer Semin Immunopathol 2005;26:329-41
14. Schmitz M, Zhao S, Deuse Y, Schakel K, Wehner R, Wohner H, et al. Tumoricidal potential of native blood dendritic cells: direct tumor cell killing and activation of NK cell-mediated cytotoxicity. J Immunol 2005;174:4127-34
15. Onaitis M, Kalady MF, Pruitt S, Tyler DS. Dendritic cell gene therapy. Surg Oncol Clin North Am 2002;11:645-60
16. Furumoto K, Soares L, Engleman EG, Merad M. Induction of potent antitumor immunity by in situ targeting of intratumoral DCs. J Clin Invest 2004;113:774-83
17. Esslinger C, Chapatte L, Finke D, Miconnet I, Guillaume P, Levy F, et al. In vivo administration of a lentiviral vaccine targets DCs and induces efficient CD8(+) T cell responses. J Clin Invest 2003;111:1673-81
18. 111Indium labeled human alveolar macrophages and monocytes: function and ultrastructure. J Immunol Methods 1980;36:99
19. Fisher B, Packard BS, Read EJ, Carrasquillo JA, Carter CS, Topalian SL, et al. Tumor localization of adoptively transferred indium-111 labeled tumor infiltrating lymphocytes in patients with metastatic melanoma. J Clin Oncol 1989;7:250
20. 111In-oxine labelling of tumor-cytotoxic macrophages generated in vitro from circulating blood monocytes: an in vitro evaluation. Nucl Med Commun 1995;16:357
21. Kuyama J, McCormack A, George AJ, Heelan BT, Osman S, Batchelor JR, et al. Indium-111 labelled lymphocytes: isotope distribution and cell division. Eur J Nucl Med 1997;24:488-96
22. Botti C, Negri DR, Seregni E, Ramakrishna V, Arienti F, Maffioli L, et al. Comparison of three different methods for radiolabelling human activated T lymphocytes. Eur J Nucl Med 1997;24:497
23. Mackensen A, Krause T, Blum U, Uhrmeister P, Mertelsmann R, Lindemann A. Homing of intravenously and intralymphatically injected human dendritic cells generated in vitro from CD34+ hematopoietic progenitor cells. Cancer Immunol Immunother 1999;48 (2-3):118-22
24. Eggert AA, Schreurs MW, Boerman OC, Oyen WJ, de Boer AJ, Punt CJ, et al. Biodistribution and vaccine efficiency of murine dendritic cells are dependent on the route of administration. Cancer Res 1999;59:3340-5
25. 99mTc-HMPAO labelling of antigen-loaded dendritic cells: in vivo imaging and influence on motility and actin content. Eur J Nucl Med Mol Imaging 2003;30:440-7
26. De Vries IJ, Krooshoop DJ, Scharenborg NM, Lesterhuis WJ, Diepstra JH, Van Muijen GN, et al. Effective migration of antigen-pulsed dendritic cells to lymph nodes in melanoma patients is determined by their maturation state. Cancer Res 2003; 63:12-7
27. Ridolfi R, Riccobon A, Galassi R, Giorgetti G, Petrini M, Fiammenghi L, et al. Evaluation of in vivo labelled dendritic cell migration in cancer patients. J Transl Med 2004;2:27
28. Eggert AA, van der Voort R, Torensma R, Moulin V, Boerman OC, Oyen WJ, et al. Analysis of dendritic cell trafficking using EGFP-transgenic mice. Immunol Lett 2003;89:17-24
29. Olasz EB, Lang L, Seidel J, Green MV, Eckelman WC, Katz SI. Fluorine-18 labeled mouse bone marrow-derived dendritic cells can be detected in vivo by high resolution projection imaging. Immunol Methods 2002;260 (1-2):137-48
30. Ahrens ET, Feili-Hariri M, Xu H, Genove G, Morel PA. Receptor-mediated endocytosis of iron-oxide particles provides efficient labeling of dendritic cells for in vivo MR imaging. Magn Reson Med 2003;49:1006-13